On (b)(6) 2018, the customer experienced suboptimal tissue processing.On (b)(6) 2018, leica biosystems was notified one case was undiagnosable and a re-biopsy was recommended, as a result of this suboptimal tissue processing.Minimal patient identifier information was provided by the customer and is found within this report.If additional information is obtained a follow up report will be submitted.
|
Following the leica biosystems manufacturer's investigation, it was determined there was no failure of the instrument which would have led to undiagnosable tissue.Confirmation as to whether the re-biopsy was performed, has not been provided to leica.See manufacturer's report number 8010478-2018-00003 follow up #01 and #02 for additional information.
|